SCHEMBL5770037

SCHEMBL5770037

CC(C)(CCCC#N)CN(C[C@H](O)[C@H](Cc1ccccc1)NC(=O)Oc1ccoc1)S(=O)(=O)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SPPL2A Q8TCT8 1/20 0.40
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MLNR O43193 1/20 0.36
ABCB11 O95342 1/20 0.36
LMNA P02545 1/20 0.36
CTSD P07339 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP3A5 P20815 1/20 0.36
CNR1 P21554 1/20 0.36
TBXAS1 P24557 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5769249 0.86 SPPL2A (0.37) SPPL2AMLNRABCB11LMNACTSD
SCHEMBL7397547 0.85 SPPL2A (0.37) SPPL2AMLNRABCB11LMNACTSD
SCHEMBL12709155 0.85 SPPL2A (0.44) SPPL2AMAPTMAPK1SMN1; SMN2MLNR
SCHEMBL1602660 0.84 MAPT (0.43) SPPL2AMAPTMAPK1SMN1; SMN2LMNA
SCHEMBL1602661 0.84 MAPT (0.43) SPPL2AMAPTMAPK1SMN1; SMN2LMNA
SCHEMBL5770036 0.84 AR (0.34) MAPTMAPK1SMN1; SMN2LMNACTSD
SCHEMBL7396185 0.82 SPPL2A (0.43) SPPL2AMLNRABCB11LMNACTSD
SCHEMBL5767519 0.81 SPPL2A (0.40) SPPL2AMLNRABCB11LMNACTSD
SCHEMBL1602014 0.81 ABCB1 (0.59) MLNRABCB11LMNACTSDCYP3A4
SCHEMBL1602012 0.81 ABCB1 (0.59) MLNRABCB11LMNACTSDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1637518-A2 Inhibitors of aspartyl protease Vertex Pharmaceuticals Incorporated (US) 2006-03-22 EP disclosed
EP-1159278-A2 INHIBITORS OF ASPARTYL PROTEASE Vertex Pharmaceuticals Incorporated (US) 2001-12-05 EP disclosed
WO-2000047551-A2 INHIBITORS OF ASPARTYL PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2000-08-17 WO disclosed